Everything below concerns metabolite. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-12-30. Where a claim depends on a specific study, the study is described rather than over-claimed.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular target | PPAR delta (NR1C2) | Ligand-activated nuclear receptor. |
| Primary tissues studied | Skeletal muscle, liver, adipose | Effects on fatty acid oxidation and energy use. |
| Typical detection matrix | Urine | Used in anti-doping analysis. |
| Common analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Sport regulatory class | Prohibited at all times | Listed as a metabolic modulator by WADA. |
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
== Clinical implications == Disposition index is used as a measure of beta cell function and the ability of the body to dispose of a glucose load. Thus a lowering of disposition index predicts the conversion of insulin resistance to diabetes mellitus type 2. Disposition index, but not insulin resistance, can predict type 2 diabetes in persons with normal blood glucose levels, but who do not have a family history (genetic predisposition) to type 2 diabetes. Disposition index can be increased by aerobic exercise, but only to the extent that insulin sensitivity is improved. The static disposition index (SPINA-DI) declines with increasing adherence to mediterranean diet. This may result from increased use of other macronutrients for the provision of energy and a reduction in the chronic stimulus for dynamical compensation with consecutive insulin hypersecretion. The disposition index is reduced in several chronic conditions including cystic fibrosis, reduced PCSK9 expression and inflammatory diseases, e.g. hidradenitis suppurativa (acne inversa).
=== Occurrence of lactobacillic acid === Following the discovery of lactobacillic acid in the lipids of Lactobacillus arabinosus, Klaus Hofmann's team was also able to determine this fatty acid in the lipids of Lactobacillus casei with a content of 16%. It is also present in L. acidophilus, L. buchneri, L. delbrueckii subsp. bulgaricus, L. delbrueckii subsp. lactis, L. fermentum and L. helveticus with a content of 10 to 30% has been detected. However, lactobacillic acid is not restricted to members of the genus Lactobacillus or lactic acid bacteria in general. The fatty acid was also found in higher proportions (10-20%) in gram-negative bacteria, such as Agrobacterium tumefaciens and Escherichia coli detected, in smaller quantities (5-10%) also in Serratia marcescens, Klebsiella aerogenes and Pseudomonas fluorescens. Brucellaspecies also contain lactobacillic acid, as well as Bordetella species, but the content here is only 1-2%. Lactobacillic acid is found in both Gram-positive and Gram-negative bacteria and is found in strictly aerobic, microaerophilic, facultative and strictly anaerobic genera. genera. Although the fatty acid is widely distributed in bacteria, it is not found in all genera. Bacteria that do not have unsaturated fatty acids in their membrane lipids do not have lactobacillic acid. This applies in particular to thermophilic bacteria and archaea. However, the fatty acid is found rather rarely in eukaryotic organisms. It is contained, for example, in rapeseed oil, which contains little erucic acid (so-called LEAR varieties).
The colonies soon entered a relatively stable state based on cooperation, intermarriage, and official policies that provided social status, education, and professional training to children of mixed Aleut-Russian birth. Within a generation, the day-to-day administration of the Russian-American colonies was largely in the hands of native-born Alaskans. Reversing the usual trend in colonization where indigenous technologies are replaced, the Russians adopted the Aleut kayak, or baidarka, sea otter hunting techniques, and the working of native copper deposits. The Russians instituted public education, preservation of the Aleut language through transliteration of religious and other texts into Aleut via an adaptation of the Cyrillic alphabet, vaccination of the native population against smallpox, and science-based sea mammal conservation policies that were ahead of their time.
== History == The individual subunits of the G protein complex were first identified in 1980 when the regulatory component of adenylate cyclase was successfully purified, yielding three polypeptides of different molecular weights. Initially, it was thought that Gα, the largest subunit, was the major effector regulatory subunit, and that Gβγ was largely responsible for inactivating the Gα subunit and enhancing membrane binding. However, downstream signalling effects of Gβγ were later discovered when the purified Gβγ complex was found to activate a cardiac muscarinic K+ channel. Shortly after, the Gβγ complex associated with a mating factor receptor-coupled G protein in yeast was found to initiate a pheromone response. Although these hypotheses were initially controversial, Gβγ has since been shown to directly regulate as many different protein targets as the Gα subunit. Recently, possible roles of the Gβγ complex in retinal rod photoreceptors have been investigated, with some evidence for the maintenance of Gα inactivation. However, these conclusions were drawn from in vitro experiments under unphysiological conditions, and the physiological role of the Gβγ complex in vision is still unclear. Nevertheless, recent in vivo findings demonstrate the necessity of the transducin Gβγ complex in the functioning of rod photoreceptors under low light conditions.
ductility Also malleability. A measure of a material's ability to undergo significant plastic deformation before rupturing, typically expressed as percent elongation or percent area reduction from a tensile test and popularly characterized by the material's ability to be stretched into a wire.
Sources: en.wikipedia.org
==== Associate of the Royal Red Cross (ARRC) ==== Staff Sergeant Natalie Dawn Davies, Queen Alexandra's Royal Army Nursing Corps, Q1048809. Major Adam Gordon Hughes, Queen Alexandra's Royal Army Nursing Corps, 30081582. Major Jennifer Elizabeth Jackson, , Queen Alexandra's Royal Army Nursing Corps, Army Reserve, 518454.
JEOL, Ltd. (日本電子, Nihon Denshi Kabushiki-kaisha; Nihon meaning Japan and Denshi meaning electron) is a major developer and manufacturer of electron microscopes and other scientific instruments, industrial equipment and medical equipment. Its headquarters are in Tokyo, Japan, with 25 domestic and foreign subsidiaries and associated companies as of 2014. It is listed in the top ten businesses worldwide for analytical laboratory instrument manufacturing. It has been included in the Activest Lux Nanotech Mutual Fund and the WestLB Nanotech Fund.
The serum total clearance of CPA is approximately 2.32 ± 0.38 mL/min/kg. Levels of CPA and 15β-OH-CPA with oral administration decrease biphasically over a period of 24 to 120 hours. The elimination of CPA appears to be biphasic. In one study, a peak at 3.4 hours post-dose with an initial half-life of 3.4 hours and later half-life of 1.6 days was observed following a single 50 mg oral dose of CPA. The high lipophilicity and fat storage of CPA may be the reason for its longer subsequent half-life.
26 February: A wildfire engulfs over 70 hectares of land near Waipoua Settlement, leading to the evacuation of local residents. Justice Minister Paul Goldsmith and Associate Justice Minister Nicole McKee confirm the Government will introduce legislation expanding citizen's arrest powers that they claim will combat retail crime. Foreign Minister Winston Peters met with Chinese Foreign Minister Wang Yi to raise concerns about Chinese naval exercises in the Tasman Sea. Police confirm they have issued a warrant to arrest a 44-year old man in connection with the arson of four Masterton churches on 22 February. 27 February – The New Zealand Government confirms it will introduce legislation to extend the parliamentary term from three to four years, subject to a referendum. 28 February: High Court Justice Simon Moore quashes Whakaari Management Limited's conviction for its role in the 2019 Whakaari / White Island eruption. Sarah Fitt resigns as chief executive of state pharmaceutical agency Pharmac. Oranga Tamariki workers affiliated with Public Service Association launch a seven-week strike avoiding double shifts, being on-call, and working overtime to protest unsatisfactory pay and work conditions.
Sources: en.wikipedia.org
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.
Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.
Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.